Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

STOP DIABETES - Knowledge-based Solutions

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test approaches to identify individuals at increased risk of type 2 diabetes and to empower them in adopting and maintaining a healthy lifestyle by combining individual and environment level strategies into a dual-process approach targeting deliberative and automatic processes of behavior. We also aim to identify barriers and facilitators of adopting a healthy lifestyle in the society, create a model for the prevention of type 2 diabetes by joint actions of health care, third sector, and other societal actors, and develop methods to monitor the cost-effectiveness of these actions. We will carry out a 1-year randomized controlled trial on the effects of among 10 000 individuals aged 18-70 years at increased risk of type 2 diabetes living in Finland. The participants will be randomized into the control group, the digital lifestyle intervention group, or the combined digital and face-to-face lifestyle intervention group. The aim of the interventions is to enhance diet quality, increase physical activity, decrease body weight, and improve glucose tolerance in individuals at increased risk of type 2 diabetes.

Who May Be Eligible (Plain English)

Who May Qualify: - age of 18-70 years - 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma glucose level 6,1 - 6,9 mmol/l) or impaired glucose tolerance (2-hour glucose level 7,8 - 11,0 mmol/l in oral glucose tolerance test) - living in the hospital district of Northern Savo, Päijät-Häme or South Karelia - possibility to use computer, smartphone or tablet with internet connection - having own self-phone number - adequate Finnish language skill Who Should NOT Join This Trial: - type 1 or 2 diabetes - pregnancy or breastfeeding - current cancer or less than 6 months from the end of cancer treatment Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * age of 18-70 years * 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma glucose level 6,1 - 6,9 mmol/l) or impaired glucose tolerance (2-hour glucose level 7,8 - 11,0 mmol/l in oral glucose tolerance test) * living in the hospital district of Northern Savo, Päijät-Häme or South Karelia * possibility to use computer, smartphone or tablet with internet connection * having own self-phone number * adequate Finnish language skill Exclusion Criteria: * type 1 or 2 diabetes * pregnancy or breastfeeding * current cancer or less than 6 months from the end of cancer treatment

Treatments Being Tested

BEHAVIORAL

Digital lifestyle intervention group

Intervention with digital application for lifestyle changes

BEHAVIORAL

Combined digital and face-to-face lifestyle intervention group

Intervention with digital application and group meetings for lifestyle changes

Locations (1)

University of Eastern Finland
Kuopio, Finland